Product NDC: | 0555-9009 |
Proprietary Name: | Nortrel |
Non Proprietary Name: | Norethindrone and Ethinyl Estradiol |
Active Ingredient(s): | .035; 1 mg/1; mg/1 & nbsp; Norethindrone and Ethinyl Estradiol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-9009 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072693 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010613 |
Package NDC: | 0555-9009-42 |
Package Description: | 3 BLISTER PACK in 1 CARTON (0555-9009-42) > 21 TABLET in 1 BLISTER PACK |
NDC Code | 0555-9009-42 |
Proprietary Name | Nortrel |
Package Description | 3 BLISTER PACK in 1 CARTON (0555-9009-42) > 21 TABLET in 1 BLISTER PACK |
Product NDC | 0555-9009 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Norethindrone and Ethinyl Estradiol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20010613 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | ETHINYL ESTRADIOL; NORETHINDRONE |
Strength Number | .035; 1 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |